Jeffrey T. Walsh, Chief Strategy Officer at bluebird bio, Inc. (BLUE), sold 500 shares at $124.00 ($62K) on 2019-08-20, disclosed to the SEC on 2019-08-21.
Open-market sale of $62k BLUE by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |
| BLUE | SELL | 2019-03-13 | $419K | — | Filing → |